MICRONOR
LOE ApproachingNDAORAL-28TABLET
Approved
Jan 1973
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
MICRONOR by Johnson & Johnson is clinical pharmacology 1. First approved in 1973.
Drug data last refreshed 6d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MICRONOR is a progestin-only oral contraceptive (norethindrone) approved in 1973 for prevention of pregnancy. It works through multiple mechanisms including suppression of ovulation in approximately 50% of users, cervical mucus thickening, and endometrial alteration. The product is indicated for women seeking hormonal contraception without estrogen.
LOE Approaching
With LOE approaching and limited current commercial activity, brand team capacity is likely minimal or consolidating toward lifecycle management and generic transition planning.
Mechanism of Action
CLINICAL PHARMACOLOGY 1. Mode of Action ORTHO MICRONOR progestin-only oral contraceptives prevent conception by suppressing ovulation in approximately half of users, thickening the cervical mucus to inhibit sperm penetration, lowering the midcycle LH and FSH peaks, slowing the movement of the ovum…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on MICRONOR offers limited growth opportunity but valuable experience in mature product management, generic transition strategy, and cost-constrained market dynamics. This role suits professionals seeking to deepen expertise in lifecycle management and value-based pricing in a stable, lower-risk environment.
Worked on MICRONOR at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.